Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection

Transplantation

Volumn 65, Issue 10, 1998, Pages 1322-1328

  Cristol, Jean Paul ^a   Vela, Carlos ^a   Maggi, Marie France ^a   Descomps, Bernard ^a   Mourad, Georges ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; LIPIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; REFERENCE VALUES;

EID: 0032571990     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199805270-00007     Document Type: Article

References (53)

1. Hostetter TH. Chronic transplant rejection. Kidney Int 1994; 46: 266.
2. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria of the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
3. Paul LC, Hayry P, Foegh M, et al. Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: joint proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs. Transpl Proc 1993; 25(2): 2022.
4. Mihatsch MJ, Ryffel B, Gudat F. Morphological criteria of chronic rejection: differential diagnosis, including cyclosporin nephropathy. Transplant Proc 1993; 25(2): 2031.
5. Paul LC. Chronic rejection of organ allografts: magnitude of the problem. Transplant Proc 1993; 25: 2024.
6. Dimeny E, Fellstrom B, Larsson E, Tufveson G, Lithell H. Chronic vascular rejection and hyperlipoproteinemia in renal transplant patients. Clin Transplant 1993; 7: 482.
7. Guijarro C, Massy Z, Kasiske L. Clinical correlation between renal allograft failure and hyperlipidemia. Kidney Int 1995; 48 (suppl 52): S56.
8. Park JW, Merz M, Braun P, Vermeltfoort M. Lipid disorders and transplant coronary artery disease in long-term survivors of heart transplantation. J Heart Lung Transplant 1996; 15(6): 572.
9. Hayry P, Mennander A, Raisanen-Sokolowski A, et al. Pathophysiology of vascular wall changes in chronic allograft rejection. Transplant Rev 1993; 7: 1.
10. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum J. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915.
11. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992; 13: 341.
12. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15: 212.
13. Cachia O, Leger C, Boulot P, et al. Red blood cell vitamin E concentrations in fetuses are related to but lower than those in mothers during gestation: a possible association with maternal lipoprotein (a) plasma levels. Am J Obstet Gynecol 1995; 173: 42.
14. Sadou H, Leger C, Descomps B, Barjon JN, Monnier L, Crastes de Paulet A. Differential incorporation of fish oil eicosapentaenoate and docosahexaenoate into lipids of lipoprotein fractions as related to their glyceryl esterification: a short-term (postprandial) and a long-term study in healthy humans. Am J Clin Nutr 1995; 62: 1193.
15. Braun WE. Long term complications of renal transplantation. Kidney Int 1990; 37: 1368.
16. Kobashigawa JA, Kasiske BL. Hyperlipidemia in solid organ transplantation. Transplantation 1997; 63: 331.
17. Chan MK, Varghese Z, Moorhead JF. Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int 1981; 19: 625.
18. Hollander AAMJ, Hene RJ, Hermans J, Van Es LA, Van der Woude FJ. Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study. J Am Soc Nephrol 1997; 8: 294.
19. Sharma AK, Myers TA, Hunninghake DB, Matas AJ, Kashtan CE. Hyperlipidemia in long term survivors of pediatric renal transplantation. Clin Transplant 1994; 8: 252.
20. Hricik DE, Bartucci MR, Mayes JT, Schulak JA. The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients. Transplantation 1992; 54: 868.
21. Kasiske BL, Tortorice KL, Heim-Duthoy KL, Awni WM, Rao KU. The adverse impact of cyclosporine on serum lipids in renal transplant recipients. Am J Kidney Dis 1991; 17: 700.
22. Hricik DE, Mayes JT, Schulack JA. Independent effects of cyclosporin and prednisone on post-transplant hypercholesterolemia. Am J Kidney Dis 1991; 18: 353.
23. Jindal RM, Popescu I, Emre S, et al. Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506. Transplantation 1994; 57: 1395.
24. Wiesner RH, Ludwig J, Van Hoek B, Krom RAF. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology 1991; 14: 721.
25. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo R. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997; 63: 1.
26. Keane WF. Lipids and the kidney. Kidney Int 1994; 46: 910.
27. Isoniemi H, Nurminen M, Tikkanen MT, et al. Risk factors predicting chronic rejection of renal allografts. Transplantation 1994; 57: 68.
28. Crastes de Faulet A, Torreilles J, Cristol JP. Membrane lipids as a preferential target for oxidative processes. In: Paoletti R, ed. Oxidative processes and antioxidants. New York: Raven Press, Ltd., 1994.
29. Jordan P, Brubacher D, Moser U, Stähelin HB, Gey KF. Vitamin E and vitamin A concentrations in plasma adjusted for cholesterol and triglycerides by multiple regression. Clin Chem 1995; 41: 924.
30. Gey KF, Puska P. Plasma vitamin E and A inversely correlated to mortality from ischemic heart disease in cross cultural epidemiology. Ann NY Acad Sci 1989; 570: 268.
31. Ceballos I, Delabar JM, Nicole A, et al. Expression of transfected human Cu/Zn superoxide dismutase gene in mouse L cells and NS2OY neuroblastoma cells induces enhancement of glutathione peroxidase activity. Biochim Biophys Acta 1988; 949: 58.
32. Jackson JR, Sampath D, Werrbach-Perez K, Perez- Polo R. Effects of nerve growth factor on catalase and glutathione peroxidase in a hydrogen peroxide-resistant pheochromocytoma sub clone. Brain Res 1994; 634: 69.
33. Nanji AA, Griniuvienne B, Sadrzadesh SMH, Levitsky S, McCully JD. Effect of type of dietary fat and ethanol on antioxidant enzyme mRNA induction in rat liver. J Lipid Res 1995; 36: 736.
34. Paul JL, Sall ND, Soni T, et al. Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 1993; 64: 106.
35. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER. Oxidative stress in haemodialysis. Q J Med 1994; 87: 679.
36. Cristol JP, Bosc JY, Badiou S, et al. Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. Nephrol Dial Transplant 1997; 12: 2312.
37. Odetti P, Garibaldi S, Gurreri G, et al. Protein oxidation in hemodialysis and kidney transplantation. Metabolism 1996; 45: 1319.
38. Maggi E, Bellazzi R, Gazo A, Seccia M, Bellomo G. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int 1994; 46: 869.
39. Hussein O, Rosemblat M, Refaeld G, Aviram M. Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low density lipoprotein in kidney transplant recipients. Transplantation 1997; 63: 679.
40. Cristol JP, Maggi MF, Vela C, Descomps B, Mourad G. Lipid metabolism and oxidative stress in renal transplantation: implications for chronic rejection. Transplant Proc 1996; 28(5): 2820.
41. Inselmann G, Blank M, Baumann K. Cyclosporine A induces lipid peroxidation in microsomes and effects on active and passive glucose transport by brush border membrane vesicles of rat kidney. Res Commun Chem Pathol Pharmacol 1988; 62: 207.
42. Serino F, Grevel J, Napoli KL, Kahan BD, Strobel HW. Oxygen radical formation by the cytochrome P450 system as a cellular mechanism for cyclosporine toxicity. Transplant Proc 1994; 26: 2916.
43. Wang C, Salahudeen AK. Lipid peroxidation accompanies cyclosporine nephrotoxicity: effects of vitamin E. Kidney Int 1995; 47: 927.
44. de Lorgeril M, Richard MJ, Arnaud J, et al. Lipid peroxides and antioxidant defenses in accelerated transplantation-associated coronary arteriosclerosis. Am Heart J 1993; 125: 974.
45. Sutherland WHF, Walker RJ, Ball MJ, Stapley SA, Robertson MC. Oxidation of low density lipoproteins from patients with renal failure or renal transplant. Kidney Int 1995; 48: 227.
46. Van Den Dorpel MA, Ghanem H, Rischen-Vos J, Man In't Veld AJ, Jansen H, Weimar W. Conversion from cyclosporine A to azathioprine treatment improves LDL oxidation in kidney transplant recipients. Kidney Int 1997; 51: 1608.
47. Ghanem H, van den Dorpel MA, Weimar W, Man In't Veld AJ, El-Kannishy MH, Jansen H. Increased low density lipoprotein oxidation in stable kidney transplant recipients. Kidney Int 1996; 49: 488.
48. Lemström K, Koskinen P, Häyry P. Molecular mechanisms of chronic allograft rejection. Kidney Int 1995; 48 (suppl 52): S2.
49. Lafont AM, Chai YC, Cornhill JF, Whitlow PL, Howe PH, Chisolm GM. Effect of alpha tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. J Clin Invest 1995; 95: 1018.
50. Nunes GL, Sgoutas DS, Redden RA, et al. Combination of vitamin C and E alters the response to coronary balloon injury in the pigs. Artioscler Thromb Vasc Biol 1995; 15: 156.
51. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, et al. Advanced glycosylation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304.
52. Turi S, Németh I, Torkos A, et al. Oxidative stress and antioxidant defense mechanism in glomerular disease. Free Radic Biol Med 1997; 22: 161.
53. Vuillemin T, Lantz O, Legendre C, et al. Potential involvement of growth factor in the proliferation of arteriolar smooth muscle cells during chronic graft rejection. Adv Nephrol 1996; 25: 39.